Artelo Biosciences, Inc. Warrant
ARTLW
ARTLW was delisted on the 17th of June, 2024.
0 hedge funds and large institutions have $0 invested in Artelo Biosciences, Inc. Warrant in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 5 closing their positions.
100% less funds holding
Funds holding: 5 → 0 (-5)
100% less capital invested
Capital invested by funds: $748 → $0 (-$748)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Verition Fund Management
Greenwich,
Connecticut
|
-$440 |
| 2 |
AGM
Alpine Global Management
New York
|
-$226 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$75 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$4 |
| 5 |
Morgan Stanley
New York
|
-$3 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Verition Fund Management
Greenwich,
Connecticut
| – | -$440 | -27,299 | Closed |
|
|
AGM
2
Alpine Global Management
New York
| – | -$226 | -14,099 | Closed |
|
|
3
UBS Group
Zurich,
Switzerland
| – | -$75 | -4,697 | Closed |
|
|
4
Bank of America
Charlotte,
North Carolina
| – | -$4 | -274 | Closed |
|
|
5
Morgan Stanley
New York
| – | -$3 | -162 | Closed |
|
ARTLW Hedge Fund Activity: Q2 2024 in Review
0 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q2 2024, worth a combined $0 — down 100% from $748 a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ARTLW and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Verition Fund Management, exiting entirely with an estimated $440 sold.
- 0 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q2 2024, down from 5 in Q1 2024.
- Funds reported $0 of Artelo Biosciences, Inc. Warrant stock for Q2 2024, down 100% quarter-over-quarter.
- 0 funds opened new Artelo Biosciences, Inc. Warrant positions in Q2 2024 and 5 closed out, a net change of -5 holders.
- The largest Artelo Biosciences, Inc. Warrant seller in Q2 2024 was Verition Fund Management, an estimated $440 sold.
Based on aggregated 13F filings for Q2 2024.